The purpose of this study is to evaluate the safety, tolerability and efficacy of ertapenem sodium as initial therapy for the treatment of complicated urinary tract infections, including pyelonephritis in indian adults.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
107
ertapenem sodium as a single dose of 1gm I.V. was infused over a 30 min interval for a minimum of 3 days to a maximum of 14 days.
Safety and tolerability
Time frame: 14 Days
Compare signs and symptoms of urinary tract infections at 14 days after treatment compared with signs and symptoms before treatment
Time frame: 14 days after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.